BRIEF-Cytrx up 8.5 percent premarket

NEW YORK Tue Jan 21, 2014 7:55am EST

NEW YORK Jan 21 (Reuters) - CytRx Corp : * Up 8.5 percent to $7.64 premarket; gets FDA OK to extend aldoxorubicin dosing cycles in late-stage trial for soft tissue sarcomas

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article